January 31, 2024 US FDA warns consumers over copycats of Bausch + Lomb eye drops The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that ...

VAUGHAN, Ontario, February 06, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better ...

From the eye care experts at Bausch and Lomb, LUMIFY works in 1 minute and lasts up to 8 hours LUMIFY is different: The only OTC drop to contain brimonidine. It selectively targets redness ...

Listen and subscribe to Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you find your favorite podcasts. After completing $300 billion in healthcare deals over several decades, there ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of ... intraocular lenses, and eye surgery products, and made revenues of $4.15 billion last year.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an ...

(Bloomberg) -- Bausch Health Cos. may kick off a new debt offering in the coming weeks as it explores options to refinance near-term liabilities, according to people with knowledge of the matter. The ...

Detailed price information for Bausch & Lomb Corp (BLCO-N) from The Globe and Mail including charting and trades.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders ...